Traders Sell Shares of CVS Health (CVS) on Strength (CVS)

Investors sold shares of CVS Health Corp (NYSE:CVS) on strength during trading on Tuesday. $158.85 million flowed into the stock on the tick-up and $232.20 million flowed out of the stock on the tick-down, for a money net flow of $73.35 million out of the stock. Of all companies tracked, CVS Health had the 0th highest net out-flow for the day. CVS Health traded up $0.64 for the day and closed at $72.31

CVS has been the subject of a number of research analyst reports. Robert W. Baird reiterated a “hold” rating and set a $77.00 price objective on shares of CVS Health in a report on Friday, October 27th. Needham & Company LLC upgraded shares of CVS Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $69.02 to $79.00 in a report on Friday, November 10th. Mizuho set a $90.00 price objective on shares of CVS Health and gave the company a “buy” rating in a report on Tuesday, October 24th. BidaskClub lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Friday, August 25th. Finally, Loop Capital initiated coverage on shares of CVS Health in a report on Thursday, August 24th. They set a “hold” rating and a $83.00 price objective for the company. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $86.35.

The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. The stock has a market cap of $73,249.45, a price-to-earnings ratio of 12.66, a P/E/G ratio of 1.36 and a beta of 0.89.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The business had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. During the same quarter in the previous year, the business posted $1.64 EPS. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. equities analysts anticipate that CVS Health Corp will post 5.9 earnings per share for the current year.

In other news, EVP Thomas M. Moriarty sold 20,547 shares of the business’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $81.17, for a total value of $1,667,799.99. Following the completion of the sale, the executive vice president now owns 43,178 shares in the company, valued at approximately $3,504,758.26. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.61% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Fieldpoint Private Securities LLC grew its position in shares of CVS Health by 333.3% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,000 shares during the last quarter. Wealthcare Advisory Partners LLC grew its position in CVS Health by 330.3% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 991 shares during the last quarter. Arcadia Investment Management Corp MI grew its position in CVS Health by 119.6% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 726 shares during the last quarter. MPS Loria Financial Planners LLC purchased a new stake in CVS Health during the 2nd quarter worth approximately $119,000. Finally, Gemmer Asset Management LLC grew its position in CVS Health by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 200 shares during the last quarter. 81.63% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Traders Sell Shares of CVS Health (CVS) on Strength (CVS)” was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.com-unik.info/2017/12/21/traders-sell-shares-of-cvs-health-cvs-on-strength-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit